KIAA1841 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.62558855265615E-12 |
Normal-vs-Stage2 |
7.50940000000533E-05 |
Normal-vs-Stage3 |
4.00059999999813E-05 |
Normal-vs-Stage4 |
1.844190E-02 |
Stage1-vs-Stage2 |
8.690600E-01 |
Stage1-vs-Stage3 |
3.045800E-01 |
Stage1-vs-Stage4 |
4.135200E-01 |
Stage2-vs-Stage3 |
3.471400E-01 |
Stage2-vs-Stage4 |
4.019200E-01 |
Stage3-vs-Stage4 |
8.720800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
9.23319976031678E-10 |
Normal-vs-Asian |
1.412970E-01 |
Caucasian-vs-AfricanAmerican |
8.774400E-01 |
Caucasian-vs-Asian |
9.664800E-01 |
AfricanAmerican-vs-Asian |
9.912200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62636570877339E-12 |
Normal-vs-Female |
8.88178419700125E-16 |
Male-vs-Female |
1.242040E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.42599999586324E-08 |
Normal-vs-Extreme_Weight |
1.68730029947994E-10 |
Normal-vs-Obese |
8.39940339503187E-11 |
Normal-vs-Extreme_Obese |
3.979400E-03 |
Normal_Weight-vs-Extreme_Weight |
9.790400E-01 |
Normal_Weight-vs-Obese |
3.771800E-01 |
Normal_Weight-vs-Extreme_Obese |
7.855000E-01 |
Extreme_Weight-vs-Obese |
3.427600E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.188200E-01 |
Obese-vs-Extreme_Obese |
7.945600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.211160E-04 |
Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
Normal-vs-Age(61-80Yrs) |
7.13873404833976E-14 |
Normal-vs-Age(81-100Yrs) |
5.865500E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.686390E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.946400E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.273900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.054600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.991590E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.206220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
<1E-12 |
Normal-VS-Type2 PRCC |
5.75680000000078E-05 |
Normal-VS-KIRP CIMP |
2.172100E-04 |
Normal-VS-Unclassified PRCC |
6.66180000052918E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.38540000005349E-06 |
Type1 PRCC-VS-KIRP CIMP |
1.949750E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.060000E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.013300E-04 |
Type2 PRCC-VS-Unclassified PRCC |
5.237200E-03 |
KIRP CIMP-VS-Unclassified PRCC |
2.178400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.46069999995557E-06 |
Normal-vs-N1 |
6.13619999999537E-05 |
Normal-vs-N2 |
2.128800E-01 |
N0-vs-N1 |
1.167170E-01 |
N0-vs-N2 |
3.655400E-01 |
N1-vs-N2 |
9.216200E-01 |
|
|